Experimental Models of Multiple Sclerosis

Front Cover
Ehud Lavi, Cris S. Constantinescu
Springer Science & Business Media, Jan 3, 2008 - Medical - 902 pages

Multiple Sclerosis (MS) is an enigmatic immune mediated disease of the central nervous system that affects about 350,000 individuals in the US, and many more around the world. The mechanism of this disease is largely unknown and there is no cure for it. However, there are several well-characterized experimental animal models that help us understand and speculate about potential mechanisms of pathology in this disease. Many of the experimental therapies designed for this disease rely on testing the drugs in animal models before using it in clinical trials. This book combines for the first time the different experimental models for MS (including immune-mediated and viral) under one roof, and highlights aspects that are different or shared among these experimental models. It’s aim is to improve our understanding of this devastating disease and help us think about potential additional therapies for it.

From inside the book

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

IV
1
V
10
VI
25
VII
45
VIII
73
IX
85
X
109
XI
132
XXXIII
593
XXXIV
617
XXXV
629
XXXVI
645
XXXVII
658
XXXVIII
673
XXXIX
684
XL
697

XII
151
XIII
180
XIV
201
XV
244
XVI
269
XVII
282
XVIII
313
XIX
343
XX
362
XXI
379
XXII
391
XXIII
414
XXIV
451
XXV
471
XXVI
491
XXVII
506
XXVIII
523
XXIX
547
XXX
561
XXXI
577
XXXII
578
XLI
709
XLII
711
XLIII
717
XLIV
736
XLV
747
XLVI
758
XLVII
771
XLVIII
780
XLIX
788
L
793
LI
804
LII
821
LIII
833
LIV
838
LV
849
LVI
859
LVII
861
LVIII
871
LIX
888
Copyright

Other editions - View all

Common terms and phrases

Popular passages

Page 126 - Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
Page 179 - LH (1995) B7-1 and B7-2 co-stimulatory molecules activate differentially the Thl/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707 62.
Page 353 - Raff MC (1992): Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
Page 80 - The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science, 1994.
Page 517 - Kerr, JFR, Wyllie, AH, and Currie, AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.
Page 232 - HL ( 1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
Page 261 - Walport. 1998. Homozygous Clq deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56.
Page 299 - TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol.
Page 340 - An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 1990; 172:1193-1200.
Page 611 - Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Bibliographic information